Antibody-medicated rejection after heart transplantation: diagnosis and clinical implications
- 16 April 2020
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Organ Transplantation
- Vol. 25 (3) , 248-254
Abstract
Purpose of review: The present article will review the diagnosis of antibody-mediated rejection in heart transplant recipients and further explore the clinical implications. Recent findings: Improved diagnostic techniques have led to increased recognition of antibody-mediated rejection and better understanding of the long-term consequences in heart transplant recipients. Endomyocardial biopsy remains the gold standard for the diagnosis of antibody-medicated ejection; however, several advances in molecular testing have emerged, including the use of gene expression profiling, messenger RNA, and microRNA. Routine surveillance of donor-specific antibodies identifies recipients at high risk for graft compromise. Additionally, new monoclonal antibody therapies have broadened our repertoire in the treatment of rejection. Summary: Advances in molecular testing for antibody-mediated rejection may improve the associated long-term complication, while minimizing risk to the patient.Keywords
This publication has 46 references indexed in Scilit:
- Intravascular macrophages in cardiac allograft biopsies for diagnosis of early and late antibody-mediated rejectionThe Journal of Heart and Lung Transplantation, 2013
- The ISHLT working formulation for pathologic diagnosis of antibody-mediated rejection in heart transplantation: Evolution and current status (2005–2011)The Journal of Heart and Lung Transplantation, 2011
- Report from a consensus conference on antibody-mediated rejection in heart transplantationThe Journal of Heart and Lung Transplantation, 2011
- Management of the sensitized adult heart transplant candidateClinical Transplantation, 2010
- The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipientsThe Journal of Heart and Lung Transplantation, 2010
- Complement Independent Antibody‐Mediated Endarteritis and Transplant Arteriopathy in MiceAmerican Journal of Transplantation, 2010
- Registry of the International Society for Heart and Lung Transplantation: Twenty-sixth Official Adult Heart Transplant Report—2009The Journal of Heart and Lung Transplantation, 2009
- Asymptomatic Antibody-mediated Rejection After Heart Transplantation Predicts Poor OutcomesThe Journal of Heart and Lung Transplantation, 2009
- Noninvasive Discrimination of Rejection in Cardiac Allograft Recipients Using Gene Expression ProfilingAmerican Journal of Transplantation, 2005
- Sirolimus in De Novo Heart Transplant Recipients Reduces Acute Rejection and Prevents Coronary Artery Disease at 2 YearsCirculation, 2004